Edition:
United States

Novocure Ltd (NVCR.OQ)

NVCR.OQ on NASDAQ Stock Exchange Global Select Market

37.55USD
20 Jul 2018
Change (% chg)

$0.25 (+0.67%)
Prev Close
$37.30
Open
$37.35
Day's High
$37.95
Day's Low
$37.05
Volume
130,618
Avg. Vol
207,236
52-wk High
$37.95
52-wk Low
$16.10

Select another date:

Thu, Apr 26 2018

BRIEF-Novocure Reports Qtrly Loss Per Share $0.23

* NOVOCURE REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES COMPANY UPDATE

BRIEF-Novocure Says Executive Chairman William Doyle's FY 2017 Total Compensation Was $23.8 Mln

* NOVOCURE LTD SAYS EXECUTIVE CHAIRMAN WILLIAM DOYLE'S FY 2017 TOTAL COMPENSATION WAS $23.8 MILLION - SEC FILING Source : https://bit.ly/2HiWTxC Further company coverage: (Reuters.Briefs@thomsonreuters.com)

BRIEF-Novocure Reports Positive Top-Line Results From Stellar Phase 2 Pilot Trial In Mesothelioma

* NOVOCURE REPORTS POSITIVE TOP-LINE RESULTS FROM STELLAR PHASE 2 PILOT TRIAL IN MESOTHELIOMA

BRIEF-NCCN Guidelines Recommend Novocure's Optune In Combination With Temozolomide

* NCCN GUIDELINES RECOMMEND OPTUNE IN COMBINATION WITH TEMOZOLOMIDE AS A CATEGORY 1 TREATMENT FOR NEWLY DIAGNOSED GLIOBLASTOMA

BRIEF-Novocure Ltd Reports Qtrly Net Loss Per Ordinary Share Of $0.12

* Q4 EARNINGS PER SHARE VIEW $-0.11, REVENUE VIEW $53.5 MILLION -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

BRIEF-Novocure Secures New $150 Mln Non-Dilutive Term Loan Financing

* NOVOCURE SECURES NEW $150 MILLION NON-DILUTIVE TERM LOAN FINANCING

Select another date: